Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

65
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

90
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
90
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

85
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
85

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Highly Selective Purification of Trace <sup>131</sup>I in Radioactive Wastewater via Adaptive Inflatable Organic Cages with Fully Accessible Sites.

Inorganic chemistry·2026
Same author

Analysis of Clinical Characteristics and Long-Term Prognosis in Young Patients with Hepatitis B Cirrhosis: A Propensity Score Matched Study.

Infection and drug resistance·2026
Same author

Higher frequency of circulating regulatory T cells is associated with poor outcomes in patients with colorectal cancer.

Discover oncology·2026
Same author

Proliferation of CD10<sup>+</sup> mature plasmacytoid dendritic cells in lymph nodes of patients with chronic non-tuberculous mycobacterial infection: a case report.

Journal of medical case reports·2025
Same author

Predictive nomogram for severe acute kidney injury in patients with cancer receiving anti-PD-1/PD-L1 antibodies: a multicenter retrospective study.

Scientific reports·2025
Same author

High Pan-Immune Inflammation Values are Associated with Prolonged Length of Hospital Stay in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

International journal of general medicine·2025

関連する実験動画

Updated: Sep 9, 2025

Reliable and High Efficiency Extraction of Kidney Immune Cells
09:15

Reliable and High Efficiency Extraction of Kidney Immune Cells

Published on: August 19, 2016

10.5K

CD4+ナイヴとCD8+エフェクタルの記憶細胞の絶対数値の低下は,慢性腎臓疾患の患者における腎臓エンドポイントの潜在的予測指標である.

Xuya Chen1, Haoyang Guo1, Danxia Jin1

  • 1Department of Clinical Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.

Renal failure
|August 31, 2025
PubMed
まとめ
この要約は機械生成です。

慢性腎臓病 (CKD) のCD4ナイブT細胞とCD8エフェクタ記憶T細胞の減少は腎臓に関する有害事象と関連しています. これらのT細胞サブセットのモニタリングは,CKDの進行と結果を予測するのに役立ちます.

キーワード:
CD4+TNCD8+TEM慢性腎臓疾患T細胞末期腎疾患

さらに関連する動画

Isolation of Mouse Kidney-Resident CD8+ T cells for Flow Cytometry Analysis
06:07

Isolation of Mouse Kidney-Resident CD8+ T cells for Flow Cytometry Analysis

Published on: June 27, 2020

6.8K
Isolation of Double Negative &#945;&#946; T Cells from the Kidney
06:56

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

12.4K

関連する実験動画

Last Updated: Sep 9, 2025

Reliable and High Efficiency Extraction of Kidney Immune Cells
09:15

Reliable and High Efficiency Extraction of Kidney Immune Cells

Published on: August 19, 2016

10.5K
Isolation of Mouse Kidney-Resident CD8+ T cells for Flow Cytometry Analysis
06:07

Isolation of Mouse Kidney-Resident CD8+ T cells for Flow Cytometry Analysis

Published on: June 27, 2020

6.8K
Isolation of Double Negative &#945;&#946; T Cells from the Kidney
06:56

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

12.4K

科学分野:

  • 免疫学
  • 腎臓科
  • 臨床医学

背景:

  • 慢性腎臓病 (CKD) の進行中のT細胞サブセットの分布については,コンセンサスがない.
  • T細胞のダイナミクスを理解することは,CKDの進行を管理し,腎臓のアウトカムを予測するために不可欠です.

研究 の 目的:

  • 循環中のT細胞サブセットのレベルをCKD患者で様々な段階で調べる.
  • CKDにおけるT細胞パラメータと腎臓のエンドポイントイベントの関係を探求する.

主な方法:

  • 130人の非透析型CKD患者 (第I-第V段階) と75人の健康な対照群を募集した.
  • 周辺血液中のT細胞サブセットを分析するために多色フロー細胞測定法を使用した.
  • 追跡期間中,腎臓のエンドポイントをモニターした.

主要な成果:

  • ステージVのCKD患者は,対照群と比較してCD4+ナイヴT (TN) / 中心記憶T (TCM) とCD8+エフェクタ記憶T (TEM) 細胞の数が著しく減少した.
  • 進行したCKDではT細胞発現パターンが変化した.
  • 高いCD4+TN (≥157/μL) とCD8+TEM (≥59/μL) 細胞数は,腎臓での有害な結果に対する独立した保護因子として特定されました.

結論:

  • 周回血液中のCD4+TNおよびCD8+TEM細胞数の減少は,慢性腎臓病患者の不良事象と相関しています.
  • これらのT細胞サブセットは,CKD進行の潜在的な予後指標として機能する.